My Cart

12.09.16 Application of GenIUL technology in viability assay as a biomarker for tuberculosis disease.

Scientists from different Research Institutes and Universities of South Africa used PhastBlue system to assess the use of vPCR to improve the specificity of Xpert MTB/RIF for the detection of viable M. tuberculosis, in clinical bacterial populations under the influence of antibiotics and sputum samples collected from pulmonary TB patients over 12 weeks of TB treatment. 

The authors showed that vPCR assay improve the specificity of Xpert MTB/RIF for viable M. tuberculosis being this effect dependent on the antibiotics tested.


Payment methods

mastercard_iconvisa_iconWe accept Credit Card and T/T payment.
Please contact us for other payment methods.

Call us

atención telefónicaIf you have any question about our products or how to purchase them, please call us.

+34 936 190 312

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.

I accept cookies from this site